招聘
Job Description:
This role will be key to further develop the country capabilities in clinical research. Under the direction of the country or cluster CRD/TA-Head the person will be responsible for the end-to-end performance of clinical trials from feasibility to close out in 1 or several countries. The role will be responsible for oversight of the employees, with line management of CRMs and functional oversights of other roles in their studies.
Responsibilities include, but are not limited to:
-
Ensures oversight and line management of the assigned Clinical Research Manager (CRM) team with supervision from CRD
-
Accountable for the successful execution, enrollment and quality of their clinical trial portfolio
-
Develop, drive and execute organizational priorities as a part of Extended LT
Qualifications, Skills and Experience:
-
Expertise in project and site management.
-
Strong understanding of clinical trial planning, management and metrics
-
Advanced digital literacy, deep understanding of the organization digital strategy and priorities
-
Ability, experience, and skills to proactively manage resource allocation, processes (and controls), productivity, quality and project and/or program delivery.
Qualification & Experience:
Required:
- 10+ years of experience in clinical research, including monitoring experience, with demonstrated success
and increasing responsibilities of which 5+ years consisted of leading projects and team
Preferred :
- Experience of Leading Teams as Project Lead, Initiative Lead, SME etc.
- Advanced degree, (e.g., Master degree, MD, PhD, PMP)
Required Skills:
Clinical Research Management, Decision Making, People Leadership
Preferred Skills:
Accountability, People Management, Resource Allocation, Team Management
Current Employees apply HERE
Current Contingent Workers apply HERE
Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.
Employee Status:
Regular
Relocation: VISA Sponsorship:Travel Requirements:
Flexible Work Arrangements:
Not Applicable
Shift: Valid Driving License:Hazardous Material(s):
Job Posting End Date:
04/26/2026
**A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
相似职位

Shift Supervisor
CVS Health · 44 W. BOYLSTON ST., Worcester, Massachusetts,United States

Area Sales Manager
3M · IN, West Bengal, Kolkata

Nursing Director Cardiac ICU - MGH
Mass General Brigham · Boston-MA

Field Director, Medical Science Liaisons - Rare Disease
Biogen · Field Locations

PHARMACY/LEAD CERTIFIED TECHNICIAN
Kroger · Brentwood, TN, United States, US
关于Merck

Merck
PublicMultinational pharmaceutical company.
10,001+
员工数
Rahway
总部位置
$208B
企业估值
评价
4.3
10条评价
工作生活平衡
4.0
薪酬
3.5
企业文化
4.2
职业发展
3.8
管理层
4.0
78%
推荐给朋友
优点
Supportive management and colleagues
Good work-life balance and flexibility
Excellent benefits and health plans
缺点
High-pressure and demanding work environment
Limited career advancement opportunities
Below-average pay for entry-level positions
薪资范围
2,504个数据点
Director
Director · Associate Director, D&A Strategy
1份报告
$176,890
年薪总额
基本工资
$153,800
股票
-
奖金
-
$176,890
$176,890
面试经验
6次面试
难度
3.0
/ 5
时长
14-28周
录用率
17%
体验
正面 0%
中性 67%
负面 33%
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Background Check
6
Offer
常见问题
Behavioral/STAR
Past Experience
Technical Knowledge
Culture Fit
Case Study
新闻动态
Merck Unveils First-in-Human Data for PD-1/VEGF Bispecific MK-2010 - Oncodaily
Oncodaily
News
·
2d ago
Does EU Approval Of ENFLONSIA Reshape The Bull Case For Merck’s Pipeline Story (MRK)? - Yahoo Finance
Yahoo Finance
News
·
2d ago
Better Pharma Dividend Stock: Novartis vs. Merck - The Motley Fool
The Motley Fool
News
·
3d ago
AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans - Fierce Biotech
Fierce Biotech
News
·
3d ago